Drug Profile
WQ 2765
Latest Information Update: 02 Jun 1998
Price :
$50
*
At a glance
- Originator Wakunaga Pharmaceutical
- Class Antibacterials; Fluoroquinolones
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 02 Jun 1998 Discontinued-Preclinical for Bacterial infections in Japan (PO)
- 31 Oct 1996 New profile
- 31 Oct 1996 Preclinical development for Bacterial infections in Japan (PO)